Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Rationale: Low‐dose ketamine is a rapid‐acting antidepressant, to which female rodents are more sensitive as compared to males. However, the mechanism mediating this sex difference in ketamine sensitivity remains elusive. Objectives: We sought to determine whether male and female mice differ in their behavioral sensitivity to low doses of ketamine, and uncover how ovarian hormones influence females’ ketamine sensitivity. We also aimed to uncover some of the molecular mechanism(s) in mood‐related brain regions that mediate sex differences in ketamine antidepressant effects. Methods: Male and female mice (freely‐cycling, diestrus 1 [D1], proestrus [Pro], or D1 treated with an estrogen receptor (ER) &agr;, ER&bgr;, or progesterone receptor (PR) agonist) received ketamine (0, 1.5, or 3 mg/kg, intraperitoneally) and were tested in the forced swim test (FST) 30 min later. Ketamine's influence over synaptic plasticity markers in the prefrontal cortex (PFC) and hippocampus (HPC) of males, D1, and Pro females was quantified by Western blot 1 h post‐treatment. Results: Males, freely cycling females, D1 and Pro females exhibited antidepressant‐like responses to 3 mg/kg ketamine. Pro females were the only group where ketamine exhibited an antidepressant effect at 1.5 mg/kg. D1 females treated with an agonist for ER&agr; or ER&bgr; exhibited an antidepressant‐like response to 1.5 mg/kg ketamine. Ketamine (3 mg/kg) increased synaptic plasticity‐related proteins in the PFC and HPC of males, D1, and Pro females. Yet, Pro females exhibited an increase in p‐Akt and p‐CaMKII&agr; in response to 1.5 and 3 mg/kg ketamine. Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ER&agr; and ER&bgr;, leading to greater activation of synaptic plasticity‐related kinases within the PFC and HPC. HIGHLIGHTSMales and diestrus 1 females exhibited antidepressant‐like responses 3 mg/kg ketamine.Females' ketamine sensitivity was increased by ovarian hormones and by estrogen receptor agonists.Proestrus behavioral ketamine sensitivity was mirrored by increased PFC activation of Akt and of HPC Akt and CaMKII&agr;.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 5×
“Previous reports posited that ketamine's up-regulation of AMPA receptor expression may underlie enhanced glutamatergic sensitivity and synaptic plasticity (Kavalali and Monteggia, 2012; Li et al., 2010).”
BackgroundResultInfluentialEpidemiology of women and depression
Kessler, R. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00426-3 · Cited by 2,006 · cited 2×
“…of some molecular mechanisms of ketamine's rapid effects, the majority of these investigations have been conducted in males; creating a serious gap in our knowledge, since females experience a two-fold increased risk of depression as compared to males (Kessler, 2003; Van de Velde et al., 2010).”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 7×
“Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ERa and ERb, leading to greater activation of synaptic plasticityrelated kinases within the PFC and HPC. © 2017 Elsevier Ltd.”
BackgroundInfluentialMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 1×
“Ketamine rapidly increases glutamate release and neuronal depolarization (H€ oflich et al., 2017; Li et al., 2017; Moghaddam et al., 1997).”
BackgroundGlycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · cited 6×
“Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ERa and ERb, leading to greater activation of synaptic plasticityrelated kinases within the PFC and HPC. © 2017 Elsevier Ltd.”
BackgroundInfluentialNMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · cited 2×
“Preclinical studies from our lab and others have shown female rodents exhibit behavioral sensitivity to doses of ketamine that are subthreshold for an antidepressant-like effect in males (Carrier and Kabbaj, 2013; Franceschelli et al., 2015; Sarkar and Kabbaj, 2016; Zanos et al., 2016).”
BackgroundSex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 1×
“pharmacokinetics and pharmacodynamics are well established (Bigos et al., 2009; Soldin and Mattison, 2009; Waxman and Holloway, 2009), and recent work by Zanos et al.”
Mechanisms of CaMKII action in long-term potentiation
Lisman, J., Yasuda, R., & Raghavachari, S. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3192 · Cited by 1,134 · cited 12×
“The amount of protein for CaMKIIa, GluR1, BDNF, MAPK, Akt, GSK-3b, and mTOR was calculated as the ratio of the optical density (OD) of the target band over the OD of the GAPDH band or from total protein.”
BackgroundInfluentialLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation
Barria, A., Muller, D., Derkach, V., Griffith, L. C., & Soderling, T. R. (1997) · Science · doi:10.1126/science.276.5321.2042 · Cited by 1,049 · cited 1×
“Of the many functions carried out by pCaMKIIa to support synaptic plasticity, one important task is the phosphorylation of the GluR1 subunit of AMPA receptors (Barria et al., 1997).”
BackgroundBDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Regulatory mechanisms of AMPA receptors in synaptic plasticity
Derkach, V. A., Oh, M. C., Guire, E. S., & Soderling, T. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2055 · Cited by 708 · cited 1×
“This supports GluR1 insertion into the synapse and can enhance channel conductivity (Derkach et al., 2007).”
BackgroundGarcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454
Long-Term Potentiation: From CaMKII to AMPA Receptor Trafficking
Herring, B. E., & Nicoll, R. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071753 · Cited by 425 · cited 12×
“The amount of protein for CaMKIIa, GluR1, BDNF, MAPK, Akt, GSK-3b, and mTOR was calculated as the ratio of the optical density (OD) of the target band over the OD of the GAPDH band or from total protein.”
BackgroundInfluentialAbdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422 · cited 1×
“The N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, has shown great promise as a rapid-acting antidepressant in humans and rodents (Abdallah et al., 2015; Kavalali and Monteggia, 2015).”
BackgroundZhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390
BDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368
Beurel, E., Song, L., & Jope, R. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.47 · Cited by 288
Acute suppression of spontaneous neurotransmission drives synaptic potentiation
Nosyreva, E., Szabla, K., Autry, A. E., Ryazanov, A. G., Monteggia, L. M., & Kavalali, E. T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-12.2013 · Cited by 283 · cited 1×
“Whole cell hippocampal extracts have also been used by other investigators to examine phosphorylation of molecular targets affected by ketamine (Autry et al., 2011; Choi et al., 2015; Gideons et al., 2014; Nosyreva et al., 2013).”
Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
Kavalali, E. T., & Monteggia, L. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040531 · Cited by 258 · cited 1×
“Previous reports posited that ketamine's up-regulation of AMPA receptor expression may underlie enhanced glutamatergic sensitivity and synaptic plasticity (Kavalali and Monteggia, 2012; Li et al., 2010).”
BackgroundLiu, R.-J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.128 · Cited by 256
Sex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251 · cited 5×
“This is based upon evidence that surgical removal of the ovaries blocked females' sensitivity and pharmacological replacement of E2/P4 restored females’ sensitivity to a male-subthreshold dose of ketamine (Carrier and Kabbaj, 2013).”
BackgroundSelf-citationGideons, E. S., Kavalali, E. T., & Monteggia, L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323920111 · Cited by 232 · cited 1×
“Whole cell hippocampal extracts have also been used by other investigators to examine phosphorylation of molecular targets affected by ketamine (Autry et al., 2011; Choi et al., 2015; Gideons et al., 2014; Nosyreva et al., 2013).”
Tuscher, J. J., Luine, V., Frankfurt, M., & Frick, K. M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3135-15.2016 · Cited by 149
Cited by
Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022489118 · Cited by 378
Muscle metabolism and atrophy: let’s talk about sex
Rosa-Caldwell, M. E., & Greene, N. P. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0257-3 · Cited by 202
“For example, female mice are more sensitive to the effects of antidepressants during proestrus [159, 160] and other pathologies such as autoimmune diseases are thought to be mediated by estrogen and the estrous/menstrual cycle [161, 162], suggesting that hormonal status may influence some disease pathologies.”
BackgroundKruse, J. L., Vasavada, M. M., Olmstead, R., Hellemann, G., Wade, B., Breen, E. C., Brooks, J. O., Congdon, E., Espinoza, R., Narr, K. L., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01268-z · Cited by 48
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Zaytseva, A., Bouckova, E., Wiles, M. J., Wustrau, M. H., Schmidt, I. G., Mendez-Vazquez, H., Khatri, L., & Kim, S. (2023) · eLife · doi:10.7554/elife.86022 · Cited by 48
“86022 8 of 28 test and novelty suppressed feeding test (Carrier and Kabbaj, 2013; Franceschelli et al., 2015; Zanos et al., 2016; Dossat et al., 2018).”
BackgroundWallace, T., & Myers, B. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.737960 · Cited by 8
Metadata
- Authors
- Dossat, A. M., Wright, K. N., Strong, C. E., & Kabbaj, M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 130
- Pages
- 30-41
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2770049007
- Cited by
- 72
- References
- 30
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.